1358-GABA介导肿瘤免疫治疗耐药及TLS功能障碍 episode artwork

EPISODE · Jul 30, 2026 · 17 MIN

1358-GABA介导肿瘤免疫治疗耐药及TLS功能障碍

from 聊聊Sci

这份研究探讨了肿瘤分泌的氨基丁酸(GABA)如何导致携带三级淋巴结构(TLS)的癌症患者对免疫治疗产生耐药性。通过对肾透明细胞癌和肉瘤的多组学分析,研究人员发现非响应者体内的GABA水平显著升高,这种神经递质会诱发B细胞功能障碍并抑制其免疫活性。空间转录组学显示,靠近GABA分泌细胞的淋巴结构表现出代谢重编程和成熟受阻。在动物模型中,使用药物阻断GABA合成能显著增强抗PD-1疗法的效果,并促进免疫细胞浸润。该成果揭示了肿瘤通过“神经模拟”逃避免疫监管的新机制,为克服免疫检查点抑制剂耐药性提供了潜在的治疗靶点。References:Hernández-Verdin I, Calvez A, Sun C M, et al. GABA promotes resistance to immunotherapy in patients with TLS-positive tumors[J]. Cancer Cell, 2026.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Jul 30, 2026

Embed this episode

Ready to play

1358-GABA介导肿瘤免疫治疗耐药及TLS功能障碍

0:00 17:28

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 17 minutes long.

When was this 聊聊Sci episode published?

This episode was published on July 30, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!